KORU Medical Systems, Inc. (KRMD) vs Korsana Biosciences, Inc. (KRSA)

A side-by-side comparison of KORU Medical Systems, Inc. and Korsana Biosciences, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — KRMD vs KRSA

growth of $100 · dividends reinvested · last 8y
KRMD +91.7% (+8.5%/yr)KRSA -98.2% (-39.7%/yr)KRMD compounded faster over this window
Log scale — wide-divergence pair
01101001kStart $100202120232025$192$2
KRMD KRSA

KRMD vs KRSA: by the numbers

  • •KRSA is the larger company ($147M vs $137M market cap).
  • •Both run net losses; KRMD's is the smaller (-4.03% vs -353.00% net margin).
  • •KRMD grew revenue faster over the past five years (16.42% vs -11.98% CAGR).

Metrics side by side

Valuation

MetricKRMDKRSA
P/S ratio3.0377.15
P/B ratio7.5828.82
FCF yield0.19%N/A

Profitability

MetricKRMDKRSA
Gross margin61.99%100.00%
Operating margin-3.66%-239.78%
Net margin-4.03%-353.00%
ROE-10.08%-131.85%
ROIC-7.95%-134.15%

Growth (annualized)

MetricKRMDKRSA
Revenue CAGR (5Y)16.42%-11.98%
Total return CAGR (5Y)1.60%-40.41%

Frequently asked

Which has grown faster, KRMD or KRSA?
Over the past five years, KRMD grew revenue faster — KRMD at a 16.42% CAGR versus KRSA at -11.98%.
How have KRMD and KRSA total returns compared?
Over the past 5 years, KRMD delivered 1.60% and KRSA delivered -40.41% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.